|
|
Volumn 2, Issue 10, 2001, Pages 899-900
|
|
Can we apply the TH1-TH2 paradigm to all lymphocytes?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA INTERFERON;
CD4 ANTIGEN;
CD56 ANTIGEN;
CD8 ANTIGEN;
CD94 ANTIGEN;
GAMMA INTERFERON;
INTERLEUKIN 12;
INTERLEUKIN 13;
INTERLEUKIN 18;
INTERLEUKIN 4;
INTERLEUKIN 5;
MONOCYTE CHEMOTACTIC PROTEIN 1;
STAT4 PROTEIN;
STAT6 PROTEIN;
T LYMPHOCYTE RECEPTOR;
TRANSCRIPTION FACTOR GATA 3;
CYTOKINE;
ANIMAL CELL;
APOPTOSIS;
ARTICLE;
CELL SURVIVAL;
DENDRITIC CELL;
HELPER CELL;
HUMAN;
HUMAN CELL;
LYMPHOCYTE DIFFERENTIATION;
LYMPHOCYTE PROLIFERATION;
LYMPHOCYTE SUBPOPULATION;
NONHUMAN;
PRIORITY JOURNAL;
STEM CELL;
TH1 CELL;
TH2 CELL;
BIOLOGICAL MODEL;
BIOSYNTHESIS;
CELL DIFFERENTIATION;
IMMUNOLOGY;
LYMPHOCYTE;
LYMPHOCYTE ACTIVATION;
NATURAL KILLER CELL;
NOTE;
PHYSIOLOGY;
CELL DIFFERENTIATION;
CYTOKINES;
HUMANS;
INTERLEUKIN-12;
INTERLEUKIN-4;
KILLER CELLS, NATURAL;
LYMPHOCYTE ACTIVATION;
LYMPHOCYTES;
MODELS, IMMUNOLOGICAL;
TH1 CELLS;
TH2 CELLS;
|
|
EID: 0034740563
PISSN: 15292908
EISSN: None
Source Type: Journal
DOI: 10.1038/ni1001-899 Document Type: Article |
|
Times cited : (23)
|
|
References (15)
|
